MARGARET ZACHEWICZ: Open Payments
NPI 1407961998 · NEW WILMINGTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,126 in 123 payments from 23 companies in 2025. Trend: 2023 $2,240 · 2024 $1,853 · 2025 $2,126
Food & beverage: $2,121Education: $5
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $379 |
| GlaxoSmithKline, LLC. | 17 | $264 |
| Novo Nordisk Inc | 12 | $225 |
| Lilly USA, LLC | 11 | $214 |
| AstraZeneca Pharmaceuticals LP | 10 | $148 |
| Otsuka America Pharmaceutical, Inc. | 7 | $139 |
| Lundbeck LLC | 7 | $137 |
| Phathom Pharmaceuticals, Inc. | 7 | $80 |
| Amgen Inc. | 4 | $68 |
| SHIELD THERAPEUTICS INC | 3 | $59 |
Products named: REXULTI, TRELEGY ELLIPTA, MOUNJARO, QULIPTA, Ozempic, VOQUEZNA, UBRELVY, FARXIGA.
Industry payments across PA — which companies pay providers there.
